Table: begin end state 1 36 cytoplasmic 37 55 transmembrane 56 64 non-cytoplasmic 65 84 transmembrane 85 93 cytoplasmic 94 113 transmembrane 114 118 non-cytoplasmic 119 141 transmembrane 142 162 cytoplasmic 163 186 transmembrane 187 197 non-cytoplasmic 198 216 transmembrane 217 244 cytoplasmic 245 263 transmembrane 264 281 non-cytoplasmic 282 302 transmembrane 303 310 cytoplasmic 311 330 transmembrane 331 335 non-cytoplasmic 336 360 transmembrane 361 371 cytoplasmic 372 393 transmembrane 394 404 non-cytoplasmic 405 423 transmembrane 424 435 cytoplasmic
Input: >N515DRAFT_0011 MNSTTAGLIARAPAMTAGQRLRSIFSGSIGNLVEWYDWYVYSAFSLYFAQVFFPASDQTT QLLNTSGIFAVGFLMRPLGGWLLGTFADRRGRKAALLLSVFMMSLGSLIIGLSPGYAQIG VAAPILLVLARLLQGLSIGGEYGTSATYLSEMAPRESRGFWSSIQYVTLVAGQLIALALL VVLQHFVLSTQQLHDWGWRIPFLIGALLAVIAVIIRRNMDETASFKKARQLESPLRTLMR HPREVLTVIGLTMGGTLAFYTFTTYMQKFLVNSAGMSKADATSISTAALFVYALLQPAFG ALSDRIGRRPLLIGFGVLGALLTYPILSTLKEAHDWWQAFGLIMAALIIVSGYTSINAVV KAELFPTEIRAIGVGLPYALALSVFGGTAEYVALWFKKIGHEDYFYWYVTACIACSLLVY IGMRDTRRHSRIVED
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server